Full name
"REMED+LECTUS" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
86.21.Z - General medical practice
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
72.20.Z - Scientific research and development in social sciences and humanities
85.5 - Non-school forms of education
86 - Healthcare
86.10.Z - Hospital activities
86.90 - Other healthcare activities
94.12.Z - Activities of membership-based professional and vocational organizations
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 1,3 | 1,6 | 1 | -36,7 |
EBITDA | 1,7 | 1,8 | 1,3 | -28,8 |
Short time liabilities | 1 | 1,2 | 1,2 | 5,2 |
Equity capital | 4,4 | 5,3 | 5,8 | 9,8 |
Operating profit (EBIT) | 1,2 | 1,5 | 1 | -37,9 |
Assets | 5,3 | 6,5 | 7 | 9 |
Net profit (loss) | 1,1 | 1,3 | 0,9 | -36,4 |
Cash | 1,6 | 2,5 | 3,2 | 28,3 |
Liabilities and provisions for liabilities | 1 | 1,2 | 1,2 | 5,4 |
Net income from sale | 11,7 | 13,8 | 16 | 15,2 |
Working assets | 3,7 | 4,8 | 5,9 | 24,3 |
Depreciation | 0,5 | 0,3 | 0,3 | 21,5 |
% | % | % | p.p. | |
Profitability of capital | 25,9 | 25,5 | 14,8 | -10,7 |
Equity capital to total assets | 82 | 81,8 | 82,4 | 0,6 |
Gross profit margin | 10,9 | 11,8 | 6,5 | -5,3 |
EBITDA Margin | 14,5 | 13,2 | 8,1 | -5,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 30 | 31 | 28 | -3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane